3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Myelodysplastic Syndromes
7
Hodgkin Disease
6
Leukemia, Biphenotypic, Acute
4
Burkitt Lymphoma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Neuroblastoma
3
Neoplasms
3
Lymphoma, Non-Hodgkin
3
Hematologic Neoplasms
3
Rhabdomyosarcoma
2
Leukemia, Myelomonocytic, Chronic
2
Teratoma
1
Solid Tumors
1
Sarcoma
1
Recurrence
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Multi-centric Castleman's Disease
1
Malignant mesenchymal tumor
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, AIDS-Related
1
Lymphoma
1
Lymphadenopathy
1
Leukemia, Myelomonocytic, Juvenile
1
Interventions
Echocardiography
2
empagliflozin
1
Social Determinants of Health
1
Hematologic Tests
1
Environmental Biomarkers
1
Carvedilol
1
Cardiography, Impedance
1
Blood Pressure Determination
1
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Filgrastim
×
90 days
×
Clear all
No trials found.